<?xml version="1.0" encoding="UTF-8"?>
<p id="par0035">Additionally, the genetic analysis of FV-PTC lesions showed increased RAS mutations rather than B-type Raf kinase (BRAF) and rearranged in transformation/papillary thyroid carcinoma (RET/PTC) rearrangements, which have been linked with classic PTC 
 <xref rid="bib0010" ref-type="bibr">[2]</xref>, 
 <xref rid="bib0025" ref-type="bibr">[5]</xref>, 
 <xref rid="bib0035" ref-type="bibr">[7]</xref>. The RAS mutations have also been described in follicular lesions of the thyroid gland such as follicular adenoma and follicular thyroid carcinoma.
</p>
